Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Aging (Albany NY) ; 12(22): 23017-23028, 2020 11 16.
Article in English | MEDLINE | ID: mdl-33197887

ABSTRACT

Human papillomavirus type 11 (HPV11) is one of the main causes of condyloma acuminatum, a widespread sexually transmitted disease. During infection of its primary target cell, keratinocytes, it is likely to encounter the autophagy pathway, which is an intracellular maintenance process that is also able to target invading pathogens. It is currently unknown whether HPV11 is targeted by autophagy or whether it is able to escape autophagy-mediated killing. Here, we investigated the autophagy response during HPV11 pseudovirion (PsV) entry in human keratinocytes. Transmission electron microscopy showed that intracellular PsVs were sequestered in lumen of double-membrane autophagosomes that subsequently appeared to fuse with lysosomes, while confocal microscopy showed induction LC3 puncta, the hallmark of induced autophagy activity. Furthermore, quantitative infection assays showed that high autophagy activity resulted in reduced HPV11 PsV infectivity. Therefore, the autophagy pathway seemed to actively target invading HPV11 PsVs for destruction in the autolysosome. Western analysis on the phosphorylation state of autophagy regulators and upstream pathways indicated that autophagy was activated through interplay between Erk and Akt signaling. In conclusion, autophagy functions as a cellular protection mechanism against intracellular HPV11 and therefore therapies that stimulate autophagy may prevent recurrent condyloma acuminatum by helping eliminate latent HPV11 infections.


Subject(s)
Autophagy , Human papillomavirus 11/pathogenicity , Keratinocytes/virology , Papillomavirus Infections/virology , Virion/pathogenicity , Virus Internalization , Autophagy-Related Proteins/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , HaCaT Cells , Host-Pathogen Interactions , Human papillomavirus 11/ultrastructure , Humans , Keratinocytes/metabolism , Keratinocytes/ultrastructure , Papillomavirus Infections/metabolism , Papillomavirus Infections/pathology , Phosphorylation , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction , TOR Serine-Threonine Kinases/metabolism , Virion/ultrastructure
3.
Lancet ; 382(9895): 889-99, 2013 Sep 07.
Article in English | MEDLINE | ID: mdl-23618600

ABSTRACT

Cervical cancer is caused by human papillomavirus infection. Most human papillomavirus infection is harmless and clears spontaneously but persistent infection with high-risk human papillomavirus (especially type 16) can cause cancer of the cervix, vulva, vagina, anus, penis, and oropharynx. The virus exclusively infects epithelium and produces new viral particles only in fully mature epithelial cells. Human papillomavirus disrupts normal cell-cycle control, promoting uncontrolled cell division and the accumulation of genetic damage. Two effective prophylactic vaccines composed of human papillomavirus type 16 and 18, and human papillomavirus type 16, 18, 6, and 11 virus-like particles have been introduced in many developed countries as a primary prevention strategy. Human papillomavirus testing is clinically valuable for secondary prevention in triaging low-grade cytology and as a test of cure after treatment. More sensitive than cytology, primary screening by human papillomavirus testing could enable screening intervals to be extended. If these prevention strategies can be implemented in developing countries, many thousands of lives could be saved.


Subject(s)
Human papillomavirus 11/pathogenicity , Human papillomavirus 16/pathogenicity , Human papillomavirus 18/pathogenicity , Papillomavirus Infections/virology , Uterine Cervical Neoplasms/virology , Cell Transformation, Neoplastic/pathology , Cell Transformation, Viral , Cross-Sectional Studies , Developing Countries , Female , Human papillomavirus 11/immunology , Human papillomavirus 11/ultrastructure , Human papillomavirus 16/immunology , Human papillomavirus 16/ultrastructure , Human papillomavirus 18/immunology , Human papillomavirus 18/ultrastructure , Human papillomavirus 6/immunology , Human papillomavirus 6/pathogenicity , Human papillomavirus 6/ultrastructure , Humans , Mass Screening , Papillomavirus Infections/epidemiology , Papillomavirus Infections/immunology , Papillomavirus Infections/pathology , Papillomavirus Infections/prevention & control , Papillomavirus Vaccines/administration & dosage , Papillomavirus Vaccines/immunology , Uterine Cervical Neoplasms/epidemiology , Uterine Cervical Neoplasms/immunology , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/prevention & control , Vaginal Smears , Virus Replication
4.
J Virol ; 82(20): 9848-57, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18701594

ABSTRACT

Polyomavirus and papillomavirus (papovavirus) capsids are composed of 72 capsomeres of their major capsid proteins, VP1 and L1, respectively. After translation in the cytoplasm, L1 and VP1 pentamerize into capsomeres and are then imported into the nucleus using the cellular alpha and beta karyopherins. Virion assembly only occurs in the nucleus, and cellular mechanisms exist to prevent premature capsid assembly in the cytosol. We have identified the karyopherin family of nuclear import factors as possible "chaperones" in preventing the cytoplasmic assembly of papovavirus capsomeres. Recombinant murine polyomavirus (mPy) VP1 and human papillomavirus type 11 (HPV11) L1 capsomeres bound the karyopherin heterodimer alpha2beta1 in vitro in a nuclear localization signal (NLS)-dependent manner. Because the amino acid sequence comprising the NLS of VP1 and L1 overlaps the previously identified DNA binding domain, we examined the relationship between karyopherin and DNA binding of both mPy VP1 and HPV11 L1. Capsomeres of L1, but not VP1, bound by karyopherin alpha2beta1 or beta1 alone were unable to bind DNA. VP1 and L1 capsomeres could bind both karyopherin alpha2 and DNA simultaneously. Both VP1 and L1 capsomeres bound by karyopherin alpha2beta1 were unable to assemble into capsids, as shown by in vitro assembly reactions. These results support a role for karyopherins as chaperones in the in vivo regulation of viral capsid assembly.


Subject(s)
Capsid/metabolism , Human papillomavirus 11/metabolism , Human papillomavirus 11/ultrastructure , Polyomavirus/metabolism , Polyomavirus/ultrastructure , Virus Assembly , alpha Karyopherins/metabolism , beta Karyopherins/metabolism , Animals , Capsid Proteins/genetics , Capsid Proteins/metabolism , DNA/metabolism , Human papillomavirus 11/genetics , Humans , Mice , Molecular Chaperones/genetics , Molecular Chaperones/metabolism , Oncogene Proteins, Viral/genetics , Oncogene Proteins, Viral/metabolism , Polyomavirus/genetics , Protein Binding , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , alpha Karyopherins/genetics , beta Karyopherins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...